Results 141 to 150 of about 2,203,437 (159)
Ebstein Anomaly: Imaging, Pathophysiology, and Therapeutics. [PDF]
Cueto-Robledo G +6 more
europepmc +1 more source
TRI-SCORE based risk stratification across contemporary treatment strategies for isolated tricuspid regurgitation: a multicenter retrospective analysis. [PDF]
Gharehdaghi S +13 more
europepmc +1 more source
Myocardial remodeling in valvular heart disease: pathophysiology, multimodality imaging and treatment implications. [PDF]
Autherith M +4 more
europepmc +1 more source
Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention [PDF]
OBJECTIVES The aim of this study was to assess the clinical outcome of baseline massive or torrential tricuspid regurgitation (TR) after transcatheter tricuspid valve intervention (TTVI). BACKGROUND The use of TTVI to treat symptomatic severe TR
Fabien Praz, Rodrigo Estevez-Loureiro
exaly +2 more sources
Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitation [PDF]
BACKGROUND AND AIMS The impact of sex in patients with significant tricuspid regurgitation (TR) undergoing transcatheter tricuspid valve intervention (TTVI) is unknown.
Fabien Praz +2 more
exaly +3 more sources
First-in-Human Transcatheter Tricuspid Valve Repair in a Patient With Severely Regurgitant Tricuspid Valve [PDF]
BackgroundSevere tricuspid regurgitation is associated with poor prognosis; however, there are limited Class I indications for intervention, and high–surgical risk patients may go untreated. We report the first-in-human successful transcatheter tricuspid
Rebecca Hahn
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:

